Top 5 Income Companies To Buy Right Now

Shares of SodaStream (NASDAQ: SODA  ) popped more than 13% during intraday trading Tuesday after the company's investor day spurred upgrades from a number of analysts.

All told, the stock is currently up a whopping 20% over the past five trading days since the Israel-based company posted stronger-than-expected results. But why, exactly, is everybody so excited today?

The $1 billion question
To be sure, I was impressed just a few days ago when the folks at SodaStream raised full-year guidance, telling investors they now expect 2013 revenue to grow around 27% to just over $554 million. Meanwhile, 2013 net income should also increase by around 20% to $52.7 million.

Yesterday, however, SodaStream management went even further, telling investors they hope to generate annual sales of at least $1 billion by 2016 -- for those of you keeping track, that would represent a more than 80% increase in sales on top of the company's already-impressive numbers. As a result, analysts at Oppenheimer raised their price target for SodaStream to $68 from $60, and the folks at Citigroup raised their price target on the stock to $66 from $60.

5 Best Insurance Stocks To Own Right Now: Japan Petroleum Exploration Co Ltd (JPTXF)

Japan Petroleum Exploration Co., Ltd. is a company principally involved in the energy business. The Company operates in four geological segments. The Japan segment involves in the production, purchase and sale of crude oil and natural gas in Japan, the contracting of drilling and refurbishment works, mud logging works, research works, geophysical exploration works, the provision of pipeline maintenance services and security guard services, the purchase and sale of petroleum products, the transportation of petroleum and natural gas products, as well as real estate management business. The North America segment involves in the exploration and development of crude oil and natural gas in North America. The Middle East segment involves in the development of crude oil and natural gas. The Others segment involves in the exploration, development and production of crude oil and natural gas in Southeast Asia. As of March 31, 2013, the Company had 26 subsidiaries and 17 associated companies. Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)

Top 5 Income Companies To Buy Right Now: ADDvantage Technologies Group Inc.(AEY)

ADDvantage Technologies Group, Inc., through its subsidiaries, distributes and services a range of electronics and hardware products for the cable television industry. The company provides new, surplus-new, and refurbished products in various brands, including Cisco, Motorola and Arris Solutions for use in connection with video, telephone and internet data signals. It offers headend products, including digital and analog satellite receivers, integrated receiver/decoders, demodulators, modulators, antennas and antenna mounts, amplifiers, equalizers, and processors for signal acquisition, processing, and manipulation for further transmission; fiber products comprising optical transmitters, fiber-optic cable, receivers, couplers, splitters, and compatible accessories for transmitting the output of cable system headend to virus locations using fiber-optic cables; and access and transport products, such as transmitters, receivers, line extenders, broadband amplifiers, direction al taps and splitters for use in permiting signals to travel from the headend to their destination in a home, apartment, hotel room, office or other terminal location. The company also provides customer premise equipment consisting of digital converter boxes and modems to receive, record, and transmit video, data, and telephony signals; and hardware equipment, such as test equipment, connector, and cable products. In addition, it offers Fujitsu Frontech North America encoders, decoders, and other media solutions products primarily for use in the broadcast industry. The company markets and sells its products to franchise and private MSOs, telephone companies, system contractors, and other resellers primarily in the United States, Canada, Central America, Mexico, and rest of South America. ADDvantage Technologies Group, Inc.was founded in 1989 and is based in Broken Arrow, Oklahoma.

Advisors' Opinion:

• [By Geoff Gannon] s to be overcapitalized. I'd much rather own a business with real earnings rather than wait for something to happen with a pile of cash.

  My question is this: How cheap is cheap enough? Clearly (to me), George Risk (RSKIA) is cheap at or even just above book value. It's a darn good business so I'm getting high quality assets and earnings power. That gets less clear when looking at lower quality businesses.

  For example:

  Solitron (SODI) sells at 74% of NCAV, has decent z- and f-scores, a FCF margin of 5.3% and an ROA of 12%.

• [By Geoff Gannon] strong>Solitron Devices (SODI)

  路 OPT-Sciences (OPST)

  Micropac

  Micropac is 76% owned by Heinz-Werner Hempel. He�� a German businessman. You can see the German company he founded here. He�� had control of Micropac for a long-time. I don�� have an exact number in front of me. But I would guess it�� been something like 25 years.

  ADDvantage

  ADDvantage Technologies is controlled by the Chymiak brothers. See the company�� April 4 press release explaining their decision to turn over the CEO position to an outsider. Regardless, the Chymiaks still control 47% of the company. Ken Chymiak is now chairman. And David Chymiak is still a director and now the company�� chief technology officer. Clearly, it�� still their company.

  By the way, the name ADDvantage Technologies has nothing to do with the Chymiaks. Today�� AEY really traces its roots to a private company called Tulsat. The Chymiak brothers acquired that company about 27 years ago. So, effectively, when you buy shares of AEY you are buying into a 27-year-old family-controlled company.

  That�� pretty typical in the world of net-nets.

  Solitron

  Solitron Devices is 29% owned by Shevach Saraf. He has been the CEO for 20 years. The post-bankruptcy Solitron has never known another CEO. Before the bankruptcy, Solitron was a much bigger, much different company. So even though we are not talking about the founder here ��and even though 70% of the company�� shares are not held by the CEO ��we��e still talking about a company where one person has a lot of control. Solitron only has three directors. Saraf is the chairman, CEO, president, CFO and treasurer. Neither of the other two directors joined the board within the last 15 years. So, we aren�� talking about a lot of tumult at the top.

  In fact, profitable net-nets seem to be especially common candidates for abandoning the responsibilities of a public company without actually getting taken priva

Top 5 Income Companies To Buy Right Now: Vivo Participacoes S.A.(VIV)

Telecomunicacoes de Sao Paulo S.A.-TELESP provides fixed-line telecommunications services to residential and commercial customers in the state of Sao Paulo, Brazil. Its services include local voice services, such as activation, monthly subscription, measured service, and public telephones; intraregional, interregional, and international long-distance voice services; data services comprising broadband services; pay TV services through direct to home satellite technology and land based wireless technology multichannel multipoint distribution service; and network services, such as interconnection and rental of facilities, as well as other services consisting of extended maintenance, caller identification, voice mail, cell phone blockers, computer support, and antivirus for Internet service subscribers. The company also offers multimedia communication services, such as audio, data, voice and other sounds, images, and texts and other information. In addition, it provides interc onnection services to cellular service providers and other fixed telecommunications companies through the use of its network. Further, the company offers telecommunications solutions and IT support designed to address the needs and requirements of companies operating various types of industries, including retail, manufacturing, services, financial institutions, and government. Telecomunicacoes de Sao Paulo S.A.-TELESP provides its products and services through person-to-person sales, telesales, indirect channels, Internet, and door-to-door sales. As of December 31, 2010, its telephone network included 11.3 million fixed lines in service, including residential, commercial, and public telephone lines; 3.3 million broadband clients; and 0.5 million pay TV clients. The company was founded in 1998 and is headquartered in Sao Paulo, Brazil. Telecomunicacoes de Sao Paulo S.A.-TELESP is a subsidiary of Telefonica S.A.

Advisors' Opinion:

• [By Inyoung Hwang]

  Royal Mail (RMG) Group Ltd. jumped the most in a month after the U.K. postal service that listed its shares in October said first-half earnings almost doubled. Vivendi SA (VIV) advanced 1.9 percent after saying it will replace its chairman once it spins off its wireless business. Accor SA dropped 3.9 percent after saying it will separate the operation and ownership of hotels into two businesses.

Top 5 Income Companies To Buy Right Now: Alexion Pharmaceuticals Inc.(ALXN)

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products for treating patients with severe and life-threatening disease states in the United States, Europe, Latin America, Japan, and the Asia Pacific. It focuses on developing products for the treatment of diseases in the areas of hematology, nephrology, neurology, ophthalmology, and cancer. The company develops and commercializes Soliris (eculizumab), a therapeutic product for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), a blood disorder. It also conducts various Phase II clinical trail programs on Soliris for its usage for the treatment of cold agglutinin disease; atypical hemolytic uremic syndrome; presensitized renal transplant; kidney transplant for catastrophic antiphospholipid syndrome; ABO incompatible renal transplant; dense deposit disease; myasthenia gravis; neuromyelitis optica; and dry a ge-related macular degeneration. In addition, the company conducts Phase IV clinical trails on Soliris for its usage for the treatment of PNH registry; and Phase I clinical trails on Samalizumab for the treatment of oncology diseases, such as chronic lymphocytic leukemia and multiple myeloma. Alexion Pharmaceuticals, Inc. serves specialty distributors and specialty pharmacies, which supply physician office clinics, hospital outpatient clinics, infusion clinics, or home health care providers; government agencies; and hospitals, hospital buying groups, pharmacies, other healthcare providers, and distributors. The company was founded in 1992 and is headquartered in Cheshire, Connecticut.

Advisors' Opinion:

• [By Ben Levisohn]

  Just after the open, Gilead was up 0.7%. Then the selling started, slowly at first. By noon it was down 0.5%; by 1 p.m. it was off 2.3%. By 2:34 p.m., Gilead was off 4.1% at $79.49, and the iShares NASDAQ Biotechnology Index (IBB) had dropped 2.5% to $261.60, despite Biogen Idec�(BIIB) getting upgraded by BMO Capital Markets and Barclays touting Alexion Pharmaceuticals (ALXN). This chart shows the damage over the course of the day.

• [By Keith Speights]

  2. Alexion Pharmaceuticals (NASDAQ: ALXN  )
  Alexion's focus on ultra-rare diseases has led to ultra-rare results. The biotech achieved a 15.1% ROIC over the past year. Its five-year average of 21.6% is even better.�

• [By Ben Levisohn]

  Werber also thinks Alexion Pharmaceuticals (ALXN), Amgen (AMGN),
  Biogen Idec (BIIB), Celgene (CELG) and Regeneron (REGN) will beat earnings.

  Gilead Sciences has gained 1% to $87.96 at 12:36 p.m. today, while Alexion Pharmaceuticals has risen 0.4% to $164.93, Amgen has advanced 1.2% to $122.48, Biogen has ticked up 0.3% to $331.90 and Regeneron has jumped 1.3% to $312.49. Celgene is little changed at $90.10.